Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma

Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma

The current developments of the new biological drugs targeting interleukin 5 (IL-5) and IL-5 receptor allowed to expand the treatment options for severe hypereosinophilic asthma. Clinicians will then be able to choose between antibodies targeting either circulating IL-5 or its receptor expressed on...

Full description

Bibliographic Details
Main Authors: Diego Bagnasco, Marco Caminati, Matteo Ferrando, Teresita Aloè, Elisa Testino, Giorgio Walter Canonica, Giovanni Passalacqua
Format: Article
Language:English
Published: Hindawi Limited 2018-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2018/5698212

Internet

http://dx.doi.org/10.1155/2018/5698212

Similar Items